-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bis-5 in Endometrial Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bis-5 in Endometrial Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bis-5 in Endometrial Cancer Drug Details: Bis5 (LB-1410) is under development for...
-
Sector Analysis
Brazil Sports Broadcasting Media (Television and Telecommunications) Market Landscape
Brazil Sports Broadcasting Media Market Report Overview The Brazil telecom and pay-TV services market size was $27.4 billion in 2022 and is expected to witness a CAGR of more than 4% during the forecast period primarily driven by increasing demand for mobile and fixed broadband connectivity. Brazil Sports Broadcasting Media Market Outlook 2022-2027 ($ Billion) Buy the Full Report to Know More About the Brazil Sports Broadcasting Media Market Forecast, Download a Free Report Sample The Brazil sports broadcasting media...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Sabatolimab in Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Sabatolimab in Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Drug Details: Sabatolimab is under development...
-
Company Insights
Innovation and Patenting activity of TIM SA Q1 2024
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of TIM SA Q1 2024". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be delivered...
-
Company Profile
TIM SA – Company Profile
TIM SA (TIM) is a provider of mobile and fixed telephony services. The company’s service portfolio include mobile fixed and long distance telephony services, data transmission services for mobile and fixed, data transmission internet services, short message services (SMS), multimedia services, video streaming, co-billing services and interconnection services. It also offers third generation (3G), fourth generation (4G) and fifth generation (5G) networks services. TIM offers products such as mobile handsets, network equipment, and accessories. The company offers WTTx technology, TIM...
Add to Basket -
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Monoclonal Antibody to Target LAG3, PD1 and TIM-3 for Solid Tumors
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry Monoclonal Antibody to Target LAG3, PD1 and TIM-3 for Solid Tumors Drug Details Tri-specific...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – CYAD-101
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry CYAD-101 Drug Details CYAD-101 is under development for the treatment of metastatic colorectal cancer....
-
Sector Analysis
Italy General Surgery Market Outlook to 2025 – Access Instruments, Aesthetic Devices, Aesthetic Lasers and Energy Devices and Others
GlobalData’s “Italy General Surgery Market Outlook to 2025” is a comprehensive databook report, covering key market data on the Italy General Surgery market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Access Instruments, Aesthetic Devices, Aesthetic Lasers and Energy Devices, Bariatric Surgery Devices, Biopsy Devices, Bronchoscopes, Chest Drainage Catheters and Units, Colonoscopes, Cystoscopes, Duodenoscopes, Embolization Particles, Endoscopy Fluid Management Systems, Endoscopy Visualization Systems and Components, Esophagoscopes & Gastroscopes, Gynecological Devices, Hernia Repair...
-
Sector Analysis
United States In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others
GlobalData’s “United States In Vitro Diagnostics Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United States In Vitro Diagnostics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Cardiac Disease, Clinical Chemistry, Hematological Disorders, Hormonal Disorders, Infectious Disease, IVD Analyzers and Reagents, Metabolic Disorder, Oncology and Women's Health. The United States In Vitro Diagnostics Market report provides key information and data on: • Annualized market...